Texas 2011 - 82nd Regular

Texas House Bill HB2165

Voted on by House
 
Out of Senate Committee
 
Voted on by Senate
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to the establishment of a medical reinsurance system and to certain insurance reforms necessary to the efficient operation of that system; providing an administrative penalty.

Impact

The introduction of HB 2165 could lead to significant changes in how health benefit plans operate within Texas, particularly for those that are self-funded. By establishing a formal reinsurance system, the bill aims to alleviate some of the financial pressures associated with high-cost claims, which could make self-funded plans more attractive for employers. Additionally, it seeks to integrate advanced financial management through established rates and assessment structures, ensuring that the system remains sustainable while providing necessary coverage. Overall, it is anticipated that this legislation would improve accessibility and affordability of healthcare services provided under these plans.

Summary

House Bill 2165 is a proposed piece of legislation designed to establish a medical reinsurance system in Texas, alongside necessary reforms to the state's insurance laws. The bill seeks to provide a structured framework for stop-loss insurance specifically for self-funded health benefit plans, thereby enhancing the state's ability to manage healthcare costs. This would involve creating a reinsurance system that would reimburse qualified claims exceeding a certain threshold, providing financial protection to health benefit plan issuers and self-funded entities. Key components of the bill outline the definitions, purposes, and necessary administrative and operational protocols for the new system.

Sentiment

Feedback on HB 2165 is largely positive from proponents who highlight its potential to streamline the insurance process and reduce financial risks for self-funded plans. Advocates argue that establishing a reinsurance system is vital to stabilize costs and enhance the viability of these plans in the marketplace. Conversely, some skeptics of the bill express concerns regarding the operational complexities and the impact on existing insurance frameworks in the state. Debates center around the effectiveness and efficiency of the proposed reinsurance system and how it might reshape the healthcare insurance landscape in Texas.

Contention

Notable points of contention surrounding HB 2165 include the appropriateness of state versus private management of the reinsurance system, and the implications this could have on health care providers and insurers. Additionally, there are discussions about the adequacy of the proposed reimbursement rates, especially in relation to existing Medicare rates, which have raised flags among healthcare advocates regarding fairness and sustainability. As stakeholders continue to weigh in, the conversation around the mechanisms for funding this reinsurance scheme remains a crucial element of the legislative discourse.

Companion Bills

No companion bills found.

Similar Bills

TX HB1578

Relating to the establishment of a medical reinsurance system and to certain insurance reforms necessary to the efficient operation of that system; providing an administrative penalty.

TX SB2383

Relating to universal health coverage for Texans.

TX SR1101

Suspending limitations on conference committee jurisdiction, S.B. No. 78.

TX HR2992

Suspending limitations on conference committee jurisdiction, S.B. No. 78.

TX SB78

Relating to promoting awareness and education about the purchase and availability of health coverage.

MN SF1074

Standardized health plan establishment to be offered in the individual and small group insurance markets

RI S0221

Provides certain controls over prescription drug costs by imposing transparency, oversight and accountability requirements on commercial insurers and their pharmacy benefit managers.

RI H5429

Provides certain controls over prescription drug costs by imposing transparency, oversight and accountability requirements on commercial insurers and their pharmacy benefit managers.